PriceTargets.com logo

NYSE:GL - Globe Life Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $99.80
  • Forecasted Upside: -4.42 %
  • Number of Analysts: 5
  • Breakdown:
  • 1 Sell Ratings
  • 2 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$104.41 As of 04/16/2021 01:00 AM ET
▲ +2.31 (2.26%)
1 month | 3 months | 12 months
Get New Globe Life Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for GL and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for GL

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$99.80
▼ -4.42% Downside Potential
This price target is based on 5 analysts offering 12 month price targets for Globe Life in the last 3 months. The average price target is $99.80, with a high forecast of $122.00 and a low forecast of $79.00. The average price target represents a -4.42% upside from the last price of $104.41.
Hold
The current consensus among 5 investment analysts is to hold stock in Globe Life. This rating has held steady since September 2019, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 1 sell ratings
Ratings as of
10/27/2019
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 2 sell ratings
Ratings as of
1/25/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 3 sell ratings
Ratings as of
4/24/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 3 sell ratings
Ratings as of
7/23/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 2 sell ratings
Ratings as of
10/21/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 1 sell ratings
Ratings as of
1/19/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 1 sell ratings
Ratings as of
3/20/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 1 sell ratings
Ratings as of
4/19/2021

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 1 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/5/2021JPMorgan Chase & Co.Boost Price TargetCautious ➝ Overweight$99.00 ➝ $103.00Low
i
4/1/2021Morgan StanleyBoost Price TargetUnderweight$95.00 ➝ $100.00Medium
i
3/3/2021Morgan StanleyBoost Price TargetUnderweight$93.00 ➝ $95.00Low
i
2/25/2021Morgan StanleyBoost Price TargetUnderweight$93.00 ➝ $95.00Medium
i
1/15/2021Morgan StanleyBoost Price TargetUnderweight$92.00 ➝ $93.00Low
i
1/6/2021Piper SandlerBoost Price TargetNeutral$87.00 ➝ $95.00N/A
i
12/4/2020Credit Suisse GroupBoost Price TargetOutperform$109.00 ➝ $122.00Medium
i
11/18/2020Morgan StanleyBoost Price TargetUnderweight$86.00 ➝ $92.00Medium
i
10/22/2020JPMorgan Chase & Co.Boost Price TargetOverweight$97.00 ➝ $99.00High
i
10/22/2020Morgan StanleyBoost Price TargetUnderweight$84.00 ➝ $86.00High
i
10/6/2020Morgan StanleyBoost Price TargetUnderweight$82.00 ➝ $84.00Medium
i
8/20/2020Morgan StanleyBoost Price TargetUnderweight$80.00 ➝ $82.00Medium
i
8/12/2020Credit Suisse GroupReiterated RatingBuyLow
i
7/23/2020Credit Suisse GroupReiterated RatingBuyLow
i
7/23/2020Morgan StanleyBoost Price TargetUnderweight$78.00 ➝ $80.00High
i
7/6/2020Morgan StanleyBoost Price TargetUnderweight$72.00 ➝ $78.00High
i
7/2/2020Piper SandlerLower Price TargetNeutral$87.00 ➝ $77.00High
i
6/5/2020Piper SandlerInitiated CoverageNeutral$87.00High
i
4/24/2020SunTrust BanksLower Price TargetHold$108.00 ➝ $79.00Low
i
4/23/2020Morgan StanleyLower Price TargetUnderweight$73.00 ➝ $72.00Medium
i
3/17/2020Morgan StanleyLower Price TargetUnderweight$91.00 ➝ $73.00High
i
1/7/2020BarclaysReiterated RatingSell$84.00Low
i
10/10/2019UBS GroupLower Price TargetSell$85.00 ➝ $84.00Low
i
9/20/2019Credit Suisse GroupInitiated CoverageOutperform$114.00Low
i
(Data available from 4/19/2016 forward)
Globe Life logo
Globe Life, Inc. is a holding company, which engages in the provision of individual life and supplemental health insurance products and services. It operates through the following segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments. The Life Insurance segment includes traditional and interest-sensitive whole life insurance as well as term life insurances. The Supplement Health Insurance segment provides generally guaranteed-renewable and include medicare supplement, critical illness, accident, and limited-benefit supplemental hospital, and surgical coverage. The Annuities segment refers to fixed-benefit contracts. The Investments segment covers the investment portfolio. The company was founded on November 19, 1979 and is headquartered in McKinney, TX.
Read More

Today's Range

Now: $104.41
$103.41
$104.62

50 Day Range

MA: $98.44
$93.40
$102.10

52 Week Range

Now: $104.41
$62.75
$104.62

Volume

492,800 shs

Average Volume

438,443 shs

Market Capitalization

$12.11 billion

P/E Ratio

15.84

Dividend Yield

0.76%

Beta

1.13

Frequently Asked Questions

What sell-side analysts currently cover shares of Globe Life?

The following Wall Street analysts have issued reports on Globe Life in the last twelve months: Credit Suisse Group AG, JPMorgan Chase & Co., Morgan Stanley, Piper Sandler, SunTrust Banks, Inc., TheStreet, and Zacks Investment Research.
View the latest analyst ratings for GL.

What is the current price target for Globe Life?

5 Wall Street analysts have set twelve-month price targets for Globe Life in the last year. Their average twelve-month price target is $99.80, suggesting a possible downside of 4.4%. Credit Suisse Group AG has the highest price target set, predicting GL will reach $122.00 in the next twelve months. SunTrust Banks, Inc. has the lowest price target set, forecasting a price of $79.00 for Globe Life in the next year.
View the latest price targets for GL.

What is the current consensus analyst rating for Globe Life?

Globe Life currently has 1 sell rating, 2 hold ratings and 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in GL, but not buy more shares or sell existing shares.
View the latest ratings for GL.

What other companies compete with Globe Life?

Other companies that are similar to Globe Life include Manulife Financial, Prudential Financial, Sun Life Financial, Swiss Re, Aviva, Legal & General Group, Lincoln National, Aegon, Athene, Sony Financial, Reinsurance Group of America, Voya Financial, Scor, Primerica and Brighthouse Financial.

How do I contact Globe Life's investor relations team?

Globe Life's physical mailing address is 3700 South Stonebridge Drive, McKinney TX, 75070. The company's listed phone number is (972) 569-4000 and its investor relations email address is [email protected] The official website for Globe Life is www.globelifeinsurance.com.